While one study observed similar blood BAFF levels in patients with or without glatiramer acetate, two other reports that MS patients treated with glatiramer acetate had significantly higher serum BAFF levels [52,98,142]. The gene discussed is TNFSF13B; the disease is myeloid sarcoma.